Literature DB >> 10084988

Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversity.

O Neyrolles1, I Chambaud, S Ferris, M C Prevost, T Sasaki, L Montagnier, A Blanchard.   

Abstract

Mycoplasma penetrans is a recently identified mycoplasma, isolated from urine samples collected from human immunodeficiency virus (HIV)-infected patients. Its presence is significantly associated with HIV infection. The major antigen recognized during natural and experimental infections is an abundant P35 lipoprotein which, upon extraction, segregates in the Triton X-114 detergent phase and is the basis of M. penetrans-specific serological assays. We report here that the P35 antigen undergoes spontaneous and reversible phase variation at high frequency, leading to heterogeneous populations of mycoplasmas, even when derived from a clonal lineage. This variation was found to be determined at the transcription level, and although this property is not unique among the members of the class Mollicutes, the mechanism by which it occurs in M. penetrans differs from those previously described for other Mycoplasma species. Indeed, the P35 phase variation was due neither to a p35 gene rearrangement nor to point mutations within the gene itself or its promoter. The P35 phase variation in the different variants obtained was concomitant with modifications in the pattern of other expressed lipoproteins, probably due to regulated expression of selected members of a gene family which was found to potentially encode similar lipoproteins. M. penetrans variants could be selected on the basis of their lack of colony immunoreactivity with a polyclonal antiserum against a Triton X-114 extract, strongly suggesting that the mechanisms involved in altering surface antigen expression might allow evasion of the humoral immune response of the infected host.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084988      PMCID: PMC96498          DOI: 10.1128/IAI.67.4.1569-1578.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  Molecular biology of mycoplasmas.

Authors:  K Dybvig; L L Voelker
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

2.  Adaptive surface antigen variation in Mycoplasma bovis to the host immune response.

Authors:  D Le Grand; M Solsona; R Rosengarten; F Poumarat
Journal:  FEMS Microbiol Lett       Date:  1996-11-01       Impact factor: 2.742

3.  Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.

Authors:  R Himmelreich; H Hilbert; H Plagens; E Pirkl; B C Li; R Herrmann
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

4.  Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos.

Authors:  M M Hayes; B J Li; D J Wear; S C Lo
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Comparative analysis of the genomes of the bacteria Mycoplasma pneumoniae and Mycoplasma genitalium.

Authors:  R Himmelreich; H Plagens; H Hilbert; B Reiner; R Herrmann
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

6.  Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab.

Authors:  H Li; J J Dunn; B J Luft; C L Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 7.  Mycoplasmas and HIV infection: from epidemiology to their interaction with immune cells.

Authors:  C Brenner; O Neyrolles; A Blanchard
Journal:  Front Biosci       Date:  1996-08-01

8.  Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity.

Authors:  S Le Gall; M C Prevost; J M Heard; O Schwartz
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

9.  Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies.

Authors:  C Citti; M F Kim; K S Wise
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

10.  Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.

Authors:  P F Mühlradt; M Kiess; H Meyer; R Süssmuth; G Jung
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

View more
  15 in total

1.  The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans.

Authors:  Yuko Sasaki; Jun Ishikawa; Atsushi Yamashita; Kenshiro Oshima; Tsuyoshi Kenri; Keiko Furuya; Chie Yoshino; Atsuko Horino; Tadayoshi Shiba; Tsuguo Sasaki; Masahira Hattori
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 2.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Occurrence, plasticity, and evolution of the vpma gene family, a genetic system devoted to high-frequency surface variation in Mycoplasma agalactiae.

Authors:  Laurent-Xavier Nouvel; Marc Marenda; Pascal Sirand-Pugnet; Eveline Sagné; Michelle Glew; Sophie Mangenot; Valérie Barbe; Aurélien Barré; Stéphane Claverol; Christine Citti
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

4.  Multiple promoter inversions generate surface antigenic variation in Mycoplasma penetrans.

Authors:  Atsuko Horino; Yuko Sasaki; Tsuguo Sasaki; Tsuyoshi Kenri
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

5.  The Variable Internal Structure of the Mycoplasma penetrans Attachment Organelle Revealed by Biochemical and Microscopic Analyses: Implications for Attachment Organelle Mechanism and Evolution.

Authors:  Steven L Distelhorst; Dominika A Jurkovic; Jian Shi; Grant J Jensen; Mitchell F Balish
Journal:  J Bacteriol       Date:  2017-05-25       Impact factor: 3.490

6.  Antigenic diversity in Eimeria maxima and the influence of host genetics and immunization schedule on cross-protective immunity.

Authors:  Adrian L Smith; Patricia Hesketh; Andrew Archer; Martin W Shirley
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  Phase variation among major surface antigens of Mycoplasma penetrans.

Authors:  K Röske; A Blanchard; I Chambaud; C Citti; J H Helbig; M C Prevost; R Rosengarten; E Jacobs
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Cross-species surface display of functional spirochetal lipoproteins by recombinant Borrelia burgdorferi.

Authors:  Wolfram R Zückert; Jill E Lloyd; Philip E Stewart; Patricia A Rosa; Alan G Barbour
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  Conservation of adjacency as evidence of paralogous operons.

Authors:  Sarath Chandra Janga; Gabriel Moreno-Hagelsieb
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

10.  Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis.

Authors:  Rohini Chopra-Dewasthaly; Martina Baumgartner; Erika Gamper; Carmen Innerebner; Martina Zimmermann; Franz Schilcher; Alexander Tichy; Petra Winter; Wolfgang Jechlinger; Renate Rosengarten; Joachim Spergser
Journal:  FEMS Immunol Med Microbiol       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.